Stock Events

Stock Events

Search...

Acadia Pharmaceuticals (ACAD) Q1 2018 Earnings

27FebConfirmed

Q2 2017

Q3 2017

Q4 2017

Q1 2018

-0.73

-0.66

-0.6

-0.53

Details

Expected EPS

-0.57

Actual EPS

-0.55

Surprise EPS

0.02

Surprise Percent

+3.51%

Description

Acadia Pharmaceuticals (ACAD) has reported earnings of -0.55 per share for Q1 2018.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.